Graft versus-host disease following allogenic bone marrow transplantation
Keywords:
transplant, GvHD, OSCCAbstract
Aplastic anaemia is a severe haematological disorder characterized by an inadequate number of hematopoietic stem cells, resulting in pancytopenia, formed by a hypocellular bone marrow. Disorders of this nature are widely treated with haematopoietic stem cell transplantation (HSCT). A potential chronic complication following (HSCT) is the growth of secondary malignancies. Notably, patients suffering from chronic graft versus host disease (cGvHD) secondary to HSCT have been shown to be more susceptible to oral squamous cell carcinoma (OSCC). Here, we present a rare case of a 30 year old Libyan woman treated with HSCT for aplastic anaemia, with subsequent complications of cGvHD and OSCC after few months of HSCT. These carcinomatous lesions were detected in the buccal gingiva and retromolar pad area at age of 31 year-old Libyan woman. The present case report emphasizes on the connection between oral cGvHD and OSCC, and the potential appearance of OSCC after HSCT at any time of patient life. Thus, closer follow-up is mandatory for all patients treated with HSCT who developed cGvHD, and efficient cGvHD prevention and therapeutic approaches are needed.
References
Medinger, M., et al., Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment. Frontiers in Oncology, 2018. 8(587).
Biswajit, H., et al., Aplastic anemia: a common hematological abnormality among peripheral pancytopenia. North American journal of medical sciences, 2012. 4(9): p. 384-388.
Clucas, D.B., L.C. Fox, and E.M. Wood, Revisiting acquired aplastic anaemia: current concepts in diagnosis and management. 2019. 49(2): p. 152-159.
Brennan, M.T., et al., Oral manifestations in patients with aplastic anemia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2001. 92(5): p. 503-8.
Curtis, R.E., et al., Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. Blood, 2005. 105(10): p. 3802-11.
Georges, G.E. and R. Storb, Hematopoietic stem cell transplantation for acquired aplastic anemia. Curr Opin Hematol, 2016. 23(6): p. 495-500.
Stoma, I., et al., Acute Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Risk Factors and Spectrum of Infectious Complications. Transplantation, 2018. 102: p. S674.
Socié, G. and J. Ritz, Current issues in chronic graft-versus-host disease. Blood, 2014. 124(3): p. 374-384.
Torres, S.R., Oral features of graft-versus-host disease. Revista brasileira de hematologia e hemoterapia, 2014. 36(1): p. 9-11.
Bauters, T., et al., Highly effective treatment with tacrolimus ointment in an adolescent with oral graft-versus-host disease. Pharm World Sci, 2010. 32(3): p. 350-2.
Bomken, S. and R. Skinner, Secondary Malignant Neoplasms Following Haematopoietic Stem Cell Transplantation in Childhood. Children (Basel, Switzerland), 2015. 2(2): p. 146-173.
Danylesko, I. and A. Shimoni, Second Malignancies after Hematopoietic Stem Cell Transplantation. Curr Treat Options Oncol, 2018. 19(2): p. 9.
Demarosi, F., et al., Squamous cell carcinoma of the oral cavity associated with graft versus host disease: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2005. 100(1): p. 63-9.
Montebugnoli, L., et al., Multiple squamous cell carcinomas of the oral cavity in a young patient with graft-versus-host disease following allogenic bone marrow transplantation. Int J Oral Maxillofac Surg, 2011. 40(5): p. 556-8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Khaled S. Ben Sala
This work is licensed under a Creative Commons Attribution 4.0 International License.
